RESUMEN
There is evidence that naturally occurring antibodies directed against Aß (nAbs-Aß) have a role in Aß-metabolism and Aß-clearance. The presence of nAbs-Aß leads to a reduction in amyloid fibrillation and thus a reduction in their toxicity. We investigated the effects of nAbs-Aß in respect to oligomerization and used the Tg2576 transgenic mouse model in order to investigate the rapid effect with a single-dose (24 h) on oligomer breakdown and cytokine secretion along with immunohistochemical characterization of synaptic plasticity. nAbs-Aß were able to reduce toxic oligomer concentration with an increase in Aß-monomers. Cytokine secretion was significantly reduced. Synaptic plasticity was also improved after administration of nAbs. Finally, single treatment lead to a significant improvement in cognition. This study demonstrates the efficacy of nAbs-Aß and presents evidence that several hallmarks of the disease are targeted by nAbs-Aß.